Desiree Priestley is the Chief Health Experience Officer at Otsuka Precision Health (OPH), where she leads commercialization efforts across health experience and support services, and digital therapeutics—including the FDA-authorized mental health PDT, Rejoyn. With over 20 years in healthcare, she’s passionate about designing care that fits into real life, not the other way around. Her work bridges complex health systems and the people they serve, driving innovation that’s both human-centered and outcomes-focused. Whether driving digital transformation or mentoring the next generation of leaders, Desiree brings a bold, human-centered vision to the future of healthcare.
Here are some key insights to help unlock the viability of PDTs to address unmet needs throughout the healthcare ecosystem — for patients and providers alike — and how to take meaningful steps to improve the health experience.